Higher Serum Endothelial-Specific Molecule-1 (ESM-1/Endocan) Levels are Associated with Poor Pathological Outcomes in Primary Bladder Cancer: A Non-randomized, Prospective, Case-Control Study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorOkucu, Emrah
dc.contributor.authorYucetas, Ugur
dc.contributor.authorKarsiyakali, Nejdet
dc.contributor.authorKoseoglu, Hikmet
dc.contributor.authorYucetas, Esma
dc.contributor.authorErkan, Erkan
dc.contributor.authorKadihasanoglu, Mustafa
dc.contributor.authorToktas, Mahmut Gokhan
dc.date.accessioned2025-10-16T15:15:48Z
dc.date.issued2023
dc.identifier.doi10.56434/j.arch.esp.urol.20237602.14
dc.identifier.otherWOS:000986818100001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6543
dc.publisherINIESTARES, S.A.
dc.sourceARCHIVOS ESPANOLES DE UROLOGIA
dc.subjectbladder cancer
dc.subjectendocan
dc.subjectESM\\-1
dc.subjectnon\\-muscle\\-invasive bladder cancer
dc.subjectmuscle\\-invasive bladder cancer
dc.subjecttumor marker
dc.titleHigher Serum Endothelial-Specific Molecule-1 (ESM-1/Endocan) Levels are Associated with Poor Pathological Outcomes in Primary Bladder Cancer: A Non-randomized, Prospective, Case-Control Study
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS